Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/INM/Capital expenditures

INMED PHARMACEUTICALS INC. (INM) Capital expenditures 2020–2025

INMED PHARMACEUTICALS INC. (INM) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.

$0FY2025 · since FY2020: $42,573 → $0
202122232425
Fiscal yearValueYoY
FY2025$0-100.0%
FY2024$9,293-94.2%
FY2023$160,014+309.2%
FY2022$39,108+2167.1%
FY2021$1,725-95.9%
FY2020$42,573—

Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.

Source: SEC XBRL filings · For reference only · Not investment advice

More INM financial trends

INM RevenueINM Net incomeINM Net marginINM Gross profitINM Gross marginINM Operating incomeINM Operating marginINM Operating cash flowINM Free cash flowINM Return on equityINM Stock buybacksINM Dividends paidINM Total assetsINM Total liabilitiesINM Shareholders’ equityINM overview →